The Clock is Ticking
By Meagan Parrish, Editor
All signs point to serialization again taking center stage in pharma in 2018. While the U.S. FDA offered the industry a yearlong sedative by delaying enforcement of the first phase of the Drug Supply Chain and Security Act (DSCSA) until next November, conventional
wisdom is that it was a one-and-done move by
That means the clock is ticking for many
companies that will need to ramp up quickly in the
new year to avoid heavy penalties.
At the recent Healthcare Packaging Expo in
Las Vegas, companies demonstrating everything
from conveyors to labeling equipment included
flexible solutions for meeting the coming
While serialization appears to be taking the
top spot among 2018 concerns, a series of other
trends are continuing to develop and may become
more prevalent going forward, including moves
in the U.S., Europe, and elsewhere to drive drug
prices down, calls for more rapid approvals of
generic drugs and biosimilars, vastly improved data
collection, analysis, and connectivity across the
supply chain, increased use
of automation, an explosion
of new technologies, and,
ultimately, the ongoing
commitment to deliver better
In addition to 2018 trends, this issue of
Pharmaceutical Processing delves into tech
transfer issues, the unique challenges with process
scale-up in generics, special door designs that keep
out contaminants, and a cover feature on UPM
Pharmaceuticals by our former editor, Meg
On a personal note I’d like to thank Meg for
her excellent work guiding our editorial coverage
over the past few years. While Meg will be missed,
I’m delighted to succeed her in the role and pledge
to continue breaking new ground in our industry
coverage. I look forward to hearing your thoughts
as we head into 2018.
Have a safe and wonderful holiday season and a
happy and prosperous year ahead!
Follow Pharmaceutical Processing Online!
Pharmaceutical Processing® (ISSN #1049-9156, USPS #001-314), is published seven times a
year. Bi-monthly in Jan/Feb, Apr/May, Jul/Aug, Sep/Oct, Nov/Dec monthly in Mar & Jun by Advantage
Business Media, 100 Enterprise Drive, Suite 600, Rockaway, NJ 07866. No part of this publication
may be reproduced in any form without prior written permission of the publisher. Opinions expressed in
articles are those of the authors and do not necessarily reflect those of Advantage Business Media.
Periodicals Mail postage paid at Rockaway, NJ 07866 and at additional mailing offices.
POSTMASTER: Send address changes/cancellations to Pharmaceutical Processing, 100 Enterprise
Drive, Suite 600, Rockaway, NJ 07866-0912, email: ABM_return@advantagemedia.com. Publications
Mail Agreement No. 41336030. Return undeliverable Canadian addresses to: Imex/Pitney Bowes, P.O.
Box 1632, Windsor Ontario N9A 7C9.
Subscriptions are free to qualified individuals.
Printed in USA: Every attempt is made to ensure the accuracy of the information contained herein,
however Advantage Business Media and its employees cannot accept responsibility for the correctness
of information supplied, advertisements, or opinions expressed. Copyright ©2017 Advantage Business
Media. All rights reserved.
Michael J. Beier,
Senior Vice President of Operations
TITAN PHARMACEUTICALS, INC.
Dr. James V. Blackwell, PhD, Consultant
BIOPROCESS TECHNOLOGY CONSULTANTS,
Ronald C. Branning,
Vice President Global Quality
Robert F. Dream, Vice President
H.D.R. COMPANY LTD.
Johanna Carmel Egan,
VGP Project Management
Girish Malhotra, President
Allan F. Pfitzenmaier, President
VECTECH PHARMA CONSULTANTS INC.
Susan Polizzotto, Manager,
R&D QA GMP Compliance
US SANOFI PASTEUR
Sr. Dir. Global Engineering
Richard G. Whitfield, Senior Director
Patrick Wong, Director of Global Engineering
BRISTOL-MYERS SQUIBB (BMS)
For subscription related matters please
contact us at: